Skip to main content

Table 2 Observed absolute values for lipid parameters [mg/dl] across the study period (mean ± standard error)

From: Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

 

Cholesterol value

HDL value

LDL value

Total triglycerides value

 

E

O

E

O

E

O

E

O

Baseline

215 ± 3.4

217 ± 3.3

57 ± 1.3

57 ± 1.4

136 ± 4.5

133 ± 4.2

136 ± 6.1

135 ± 5.8

6 mo

227 ± 4.2

226 ± 5.8

56 ± 1.6

60 ± 1.5

149 ± 4.5

143 ± 7.3

116 ± 7

127 ± 7.8

12 mo

228 ± 4.2

231 ± 4.5

53 ± 1.4

60 ± 1.7

152 ± 4.9

145 ± 4.3

111 ± 5.5

117 ± 6

18 mo

234 ± 6

228 ± 6

51 ± 1.8

60 ± 2.1

161 ± 7.7

145 ± 6.8

121 ± 6.5

111 ± 9

24 mo

228 ± 5.6

230 ± 4.8

52 ± 1.9

62 ± 1.9

154 ± 6.3

136 ± 6.5

112 ± 6.5

118 ± 7.8

  1. E = Exemestane; O = Observation.